Single-dose AME Study With [14C]AR882 in Healthy Male Subjects

Summary

This is an open-label, single-dose, absorption, metabolism, excretion, and mass balance study following a single dose of \[14C\]AR882 in healthy adult male subjects. Whole blood, plasma, urine, and fecal samples will be analyzed for at least 144 hours following the single dose of AR882 to measure total radioactivity and plasma drug concentrations.

Timeline

Start

2020-07-16

Primary completion

2020-08-12

Completion

2020-08-12

Drugs

Indications

No indication recorded.